David A. Horwitz, MD

Founder
General Nanotherapeutics, LLC
Santa Monica, California, United States

Disclosure information not submitted.

Presentation(s):

• Tolerogenic IL-2 Containing Nanoparticles Induce CD4 and CD8 Regulatory T Cells and TGF-β Producing Regulatory NK Cells That Provide Essential Support for the Tregs Which Suppress Immune-mediated Disorders

  Thursday, June 20, 2024
  3:15 PM – 3:30 PM PT